Skip to content

Electric-Acoustic Stimulation Extended Follow-up Post Approval Study

Office of Device Evaluation Lead-MED-EL EAS Extended f/u Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03031678
Enrollment
50
Registered
2017-01-25
Start date
2016-12-31
Completion date
2019-12-31
Last updated
2020-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Sensorineural

Brief summary

The MED-EL EAS Extended Follow-up Study is an extended follow-up of the subjects who were enrolled in the pivotal study to assess long-term safety and device performance.

Detailed description

The study will be conducted as a prospective, non-controlled, non-randomized, multicenter study at the 14 sites. Up to 68 available subjects who were enrolled in the pivotal study will be invited to participate in the extended follow-up. Study subjects will be followed for a minimum of 5 years post-implantation of the device.

Interventions

DEVICEElectric-Acoustic Stimulation (EAS) Cochlear Implant System

Combination of a cochlear implant and a hearing aid

Sponsors

Med-El Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older at the time of implantation * Severe to profound sensorineural hearing loss for frequencies greater than 1500 Hz (i.e., threshold no better than 70 dB HL at 2000-8000 Hz) * Low-frequency thresholds up to and including 500 Hz no poorer than 65 dB HL * CNC word recognition score less than or equal to 60% in the ear to be implanted * CNC word recognition score less than or equal to 60% in the contralateral ear * English spoken as the primary language

Exclusion criteria

* Conductive, retrocochlear, or central auditory disorder * Hearing loss in the ear to be implanted that has demonstrated a recent fluctuation at two or more frequencies of 15 dB in either direction in the last 2 years * Any physical, psychological, or emotional disorder that interferes with surgery or the ability to perform on test and rehabilitation procedures * Developmental delays or organic brain dysfunction * Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations * Unwillingness or inability of the candidate to comply with all investigational requirements

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Words Correct As Assessed by CUNY Sentence Test.Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trialLong-term effectiveness of the Electric-Acoustic System will be assessed by speech perception testing in noise with CUNY sentences completed through five years post-implantation.

Secondary

MeasureTime frameDescription
Classification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trialThe HEARRING Scale was developed by the HEARRING Research Group, a collaboration of surgeons and audiologists in the hearing implant field who work together to develop consensus statements. The Scale was published in 2013 by Skarzynski et al. as means to classify post-operative residual hearing thresholds. Residual hearing is classified as complete (100-76%), partial (26-75%), minimal (1-25%), or none (0%) according to an equation which takes into account pre-operative thresholds, post-operative thresholds, and the limits of the audiometer.
Percentage of Words Correct as Assessed by CNC Words in Quiet.Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trialLong-term effectiveness of the Electric-Acoustic System will be assessed by speech perception testing in quiet with CNC words completed through five years post-implantation.
Subjective Benefit From EAS Through 5 Years Post Implantation Measured on the APHAB (Abbreviated Profile Hearing Aid Benefit) Questionnaire.Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trialThe APHAB Questionnaire measures percentage of listening difficulty on a scale from 100% (very difficult) to 0% (not difficult at all). Results are reported as the average listening difficulty across subjects.

Countries

United States

Participant flow

Participants by arm

ArmCount
Study Procedures
Electric-Acoustic Stimulation (EAS) Cochlear Implant System: Combination of a cochlear implant and a hearing aid
50
Total50

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyStudy closed prior to completion1

Baseline characteristics

CharacteristicStudy Procedures
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
39 Participants
Age, Continuous55.58 years
STANDARD_DEVIATION 13.24
Ear Implanted
Left
23 Participants
Ear Implanted
Right
27 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
50 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
8 / 50

Outcome results

Primary

Percentage of Words Correct As Assessed by CUNY Sentence Test.

Long-term effectiveness of the Electric-Acoustic System will be assessed by speech perception testing in noise with CUNY sentences completed through five years post-implantation.

Time frame: Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trial

ArmMeasureValue (MEAN)Dispersion
Electric Acoustic StimulationPercentage of Words Correct As Assessed by CUNY Sentence Test.61.33 percentage of words correctStandard Deviation 27.05
CI AlonePercentage of Words Correct As Assessed by CUNY Sentence Test.43.30 percentage of words correctStandard Deviation 33.1
Secondary

Classification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.

The HEARRING Scale was developed by the HEARRING Research Group, a collaboration of surgeons and audiologists in the hearing implant field who work together to develop consensus statements. The Scale was published in 2013 by Skarzynski et al. as means to classify post-operative residual hearing thresholds. Residual hearing is classified as complete (100-76%), partial (26-75%), minimal (1-25%), or none (0%) according to an equation which takes into account pre-operative thresholds, post-operative thresholds, and the limits of the audiometer.

Time frame: Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trial

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Electric Acoustic StimulationClassification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.Complete Hearing Preservation6 Participants
Electric Acoustic StimulationClassification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.Minimal Hearing Perservation9 Participants
Electric Acoustic StimulationClassification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.No Hearing Preservation4 Participants
Electric Acoustic StimulationClassification of Residual Hearing at 5 Years Post Operatively as a Function of the HEARRING SCALE.Partial Hearing Preservation31 Participants
Secondary

Percentage of Words Correct as Assessed by CNC Words in Quiet.

Long-term effectiveness of the Electric-Acoustic System will be assessed by speech perception testing in quiet with CNC words completed through five years post-implantation.

Time frame: Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trial

ArmMeasureValue (MEAN)Dispersion
Electric Acoustic StimulationPercentage of Words Correct as Assessed by CNC Words in Quiet.73.59 percentage of words correctStandard Deviation 13.71
CI AlonePercentage of Words Correct as Assessed by CNC Words in Quiet.57.40 percentage of words correctStandard Deviation 23.29
Secondary

Subjective Benefit From EAS Through 5 Years Post Implantation Measured on the APHAB (Abbreviated Profile Hearing Aid Benefit) Questionnaire.

The APHAB Questionnaire measures percentage of listening difficulty on a scale from 100% (very difficult) to 0% (not difficult at all). Results are reported as the average listening difficulty across subjects.

Time frame: Five years (60 months) post-implantation for subjects implanted under the original EAS clinical trial

Population: 46 completed the questionnaire

ArmMeasureValue (MEAN)Dispersion
Electric Acoustic StimulationSubjective Benefit From EAS Through 5 Years Post Implantation Measured on the APHAB (Abbreviated Profile Hearing Aid Benefit) Questionnaire.35.39 percentage of listening difficultyStandard Deviation 13.89

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026